Wellington Management Group
GBT

Wellington Management Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Wellington Management Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-37,029
Closed -$2.52M – 2197
2022
Q3 		$2.52M Sell
37,029
-564,952
-94% -$31.2M ﹤0.01% 1467
2022
Q2 		$19.2M Buy
601,981
+567,120
+1,627% +$16.6M ﹤0.01% 956
2022
Q1 		$1.21M Sell
34,861
-7,245
-17% -$217K ﹤0.01% 1706
2021
Q4 		$1.23M Buy
42,106
+970
+2% +$30K ﹤0.01% 1769
2021
Q3 		$1.05M Sell
41,136
-1,393,591
-97% -$41M ﹤0.01% 1790
2021
Q2 		$50.2M Sell
1,434,727
-289,401
-17% -$11.3M 0.01% 825
2021
Q1 		$70.3M Sell
1,724,128
-313,992
-15% -$14.4M 0.01% 712
2020
Q4 		$88.3M Sell
2,038,120
-220,075
-10% -$10.9M 0.02% 623
2020
Q3 		$125M Sell
2,258,195
-146,855
-6% -$9.33M 0.03% 477
2020
Q2 		$152M Sell
2,405,050
-359,214
-13% -$24.6M 0.03% 420
2020
Q1 		$141M Sell
2,764,264
-130,221
-4% -$8.72M 0.04% 387
2019
Q4 		$230M Sell
2,894,485
-906,877
-24% -$53.7M 0.05% 365
2019
Q3 		$184M Buy
3,801,362
+248,068
+7% +$12.9M 0.04% 403
2019
Q2 		$187M Sell
3,553,294
-48,976
-1% -$2.81M 0.04% 385
2019
Q1 		$191M Sell
3,602,270
-91,418
-2% -$4.49M 0.04% 379
2018
Q4 		$152M Sell
3,693,688
-146,222
-4% -$5.48M 0.04% 395
2018
Q3 		$146M Sell
3,839,910
-176,513
-4% -$7.82M 0.03% 466
2018
Q2 		$182M Sell
4,016,423
-324,768
-7% -$14.8M 0.04% 400
2018
Q1 		$210M Buy
4,341,191
+2,214,424
+104% +$124M 0.05% 366
2017
Q4 		$83.7M Sell
2,126,767
-341,226
-14% -$12.7M 0.02% 622
2017
Q3 		$76.6M Buy
2,467,993
+119,137
+5% +$3.35M 0.02% 626
2017
Q2 		$64.2M Buy
2,348,856
+27,733
+1% +$825K 0.02% 656
2017
Q1 		$85.5M Buy
2,321,123
+225,994
+11% +$5.69M 0.02% 565
2016
Q4 		$30.3M Sell
2,095,129
-70,382
-3% -$1.24M 0.01% 867
2016
Q3 		$49.9M Buy
2,165,511
+545,465
+34% +$10.4M 0.01% 695
2016
Q2 		$26.9M Buy
1,620,046
+1,197,490
+283% +$24.2M 0.01% 853
2016
Q1 		$6.7M Sell
422,556
-577,946
-58% -$10.3M ﹤0.01% 1269
2015
Q4 		$32.3M Buy
1,000,502
+314,788
+46% +$13.6M 0.01% 812
2015
Q3 		$28.3M Buy
+685,714
New +$32.3M 0.01% 855

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wellington Management Group's GBT Position: Q4 2022 in Review

Wellington Management Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 37,029 shares — an estimated $2.52M sold.

Wellington Management Group first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $230M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Wellington Management Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wellington Management Group sold 37,029 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2.52M.
  • Wellington Management Group first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
  • Wellington Management Group's Global Blood Therapeutics, Inc. position peaked at $230M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.